title: Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
abstract: OBJECTIVE
  To evaluate the distributions of body mass index in a large sample of patients with schizophrenia, and to examine the association between body weight and antipsychotic drugs.
  
  
  METHODS
  The data source was baseline data from a national survey conducted in 2005-2006 in 5756 patients.
  
  
  RESULTS
  The mean age of the patients was 37.1 +/- 11.8 years, and the mean BMI was 25.5 +/- 5.2 kg/m(2). In the final logistic regression model, the prevalence of obesity was significantly higher in female patients, age 40-59 vs. 18-29 years, patients in sheltered employment (vs. no income), out-patients (vs. full-time in-patients) and patients treated with concomitant antidepressant. There was a higher rate of obesity, relative to an absence of antipsychotics at entry, for patients receiving the following individual drugs: clozapine, olanzapine, risperidone and amisulpride.
  
  
  CONCLUSIONS
  In patients treated with atypical antipsychotics, we found a significantly higher prevalence of obesity than in those not treated with any antipsychotic medication.
authors.affiliation: Department of Psychiatry, University of Reims, Reims, France. frederic.limosin@runbox.com
authors.forename: F
authors.initials: F
authors.lastname: Limosin
authors.forename: I
authors.initials: I
authors.lastname: Gasquet
authors.forename: D
authors.initials: D
authors.lastname: Leguay
authors.forename: J-M
authors.initials: JM
authors.lastname: Azorin
authors.forename: F
authors.initials: F
authors.lastname: Rouillon
mesh_terms: D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care / Q000706:statistics & numerical data; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects; D015331:Cohort Studies; D015897:Comorbidity; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000139:chemically induced / Q000453:epidemiology*; D050177:Overweight / Q000139:chemically induced / Q000453:epidemiology*; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology*; D012737:Sex Factors; D012759:Sheltered Workshops / Q000706:statistics & numerical data
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents